The BioScience segment comprises research-intensive, custom solutions based on enzyme technology, strain development, bioprocess development and natural product screening. We are the partner of choice when industry is looking for innovative biobased solutions.
Our innovative strength is based on a comprehensive portfolio of biotechnological and analytical methods as well as an intensive scientific, interdisciplinary and application-oriented exchange within the three technology units at the Zwingenberg site. Combined with an agile way of working and a close exchange with colleagues at our production sites, the requirements of our customers lead to innovative solutions for their processes or products.
Development of new enzyme products
Through our R&D activities at the Zwingenberg site, we are continuously expanding our product portfolio with innovative specialty enzymes. The BRAIN Biotech AG bioarchive contains approximately 53,000 comprehensively characterized microorganisms, chassis microorganism strains for the development of production organisms and genetic libraries with new enzymes and metabolic pathways. The collection is being expanded in ongoing projects and allows the identification of previously uncharacterized enzymes and new access to previously uncultivable microorganisms.
Expansion of substance libraries
The Potsdam site has a collection of pure natural compounds and semi-synthetic compounds based on natural building blocks. The collection also includes small molecules. These can be the starting point for screening, e.g. for drug candidates for pharmaceutical applications.
